2003 FDA Vaccines 
PharmaShots
APRIL 13, 2023
Through the inclusion of Pharmacia’s products along with a strong performance, Pfizer’s pharmaceutical and animal health revenue was boosted by 40% and 43% respectively In the year 2003, Johnson & Johnson generated a revenue of $41.9B which depicted a growth of 15.3% as compared to the previous year. from last year.
STAT
JULY 6, 2023
agency and Colombian authorities of problems at the Caucaseco Scientific Research Center and the Malaria Vaccine Development Center. Both are run by a husband-and-wife team that has received more than $17 million in NIH funding since 2003, according to the animal rights group.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ISPE
OCTOBER 26, 2022
ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. FDA CFR Title 21 Parts 211, 600, and 1271; 8. , Complete Data Gathering.
Pharmaceutical Technology
APRIL 11, 2023
The US Food and Drug Administration (FDA) has granted final approval to India-based Zydus Lifesciences ‘ 500mg azithromycin tablets for the treatment of bacterial infections. Zydus, which currently has 360 approvals, has filed abbreviated new drug applications for more than 440 drugs since 2003-04.
European Pharmaceutical Review
SEPTEMBER 22, 2023
Limitations of monoclonal antibody therapies Regulatory approvals from the US Food and Drug Administration (FDA) for aducanumab and lecanemab – and likely very soon for donanemab also – opened a route for different therapeutic modalities and other relevant disease targets, such as tau.
PharmaShots
FEBRUARY 20, 2023
However, upstream production in plants must also comply with additional laws relating to environmental release if grown outdoors (Directive 2001/ 18/EC, and 1829/2003/EC if the crop can be used as food/ feed) and Directive 2009/41EC if grown in constraint. However, these VLPs do not contain genetic material, making them non-infectious.
The Checkup by Singlecare
NOVEMBER 13, 2023
To help decrease the risk of shingles, Shingrix vaccine is FDA-approved for adults 50 and older. It is a two-vaccine series and significantly decreases the risk of a shingles outbreak. Antiviral medications such as Acyclovir ( zovirax ) and famciclovir are often prescribed.
Expert insights. Personalized for you.
40 
Let's personalize your content